After the Supreme Court’s reversal of IEEPA tariffs, a new combination of Section 232 and Section 301 tariffs is rapidly reshaping the trade landscape for US importers. Legal and trade advisers at
Novo Nordisk’s chief executive has signalled openness to listing the Danish drugmaker’s shares directly on the New York Stock Exchange. CEO Doustdar told a newspaper that he sees clear advantages in pursuing
More
Chancellor John Healey and Prime Minister Andy Burnham could raise £26bn through sweeping reforms to capital gains taxes and national insurance contributions, according to a new academic proposal. Researchers at the Centre
More
A federal court has vacated a sweeping Education Department directive that led to the cancellation of more than $600 million in teacher training grants tied to diversity, equity, and inclusion programming. The
More
The Eighth Circuit has drawn sharp criticism after judges were accused of distorting federal procedure to deliver a ruling favourable to the Trump administration. Legal commentators have labelled the judges involved as
More
Lowe’s Companies (NYSE: LOW) remains one of the most closely watched benchmarks in the home improvement and furnishing retail sector heading into mid-2026. The home improvement retail industry has faced significant headwinds
More
Britain’s most promising businesses are being held back by surging employment costs and persistent difficulties attracting skilled workers, new research has found. A survey of 423 leaders of high-growth companies by Enterprise
More
In a significant Texas probate ruling, an appeals court has affirmed summary judgment in favour of executors, finding the plaintiffs’ claims were barred by the statute of limitations. The case, Conover v.
More
The CPHI Milan Leadership Summit is set to return with a sharp focus on supply chain resilience, one of the pharmaceutical industry’s most pressing concerns heading into late 2026. Supply chain disruption
More
Airtel Africa (LSE: AAF) has been among the standout performers in the FTSE 100 since joining the blue-chip index in January 2022, surging 124% over that period. Investors who backed the African
More
Accenture (ACN) is among a handful of stocks drawing significant investor attention as markets prepare to open for the new trading week. Abivax (ABVX), the French biopharmaceutical company, is also on the
More